41
Participants
Start Date
July 31, 2011
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
Buprenorphine transdermal system
Buprenorphine transdermal system 2.5 mcg/h, 5 mcg/h, 10 mcg/h or 20 mcg/h applied transdermally for 7-day wear.
WCMC, Department of Pediatrics - Hematology/Oncology, New York
Children's Hospital at Montefiore, The Bronx
Stony Brook University Hospital, Stony Brook
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Howard University Hospital, Washington D.C.
The Center for Clinical Research - Carolina Pain Institute, Winston-Salem
Vidant Medical Center, Greenville
Medical University of South Carolina, Charleston
Children's Healthcare of Atlanta at Egleston, Atlanta
Jackson Memorial Hospital / University of Miami, Miami
Kosair Charities Pediatric Clinical Research Unit - University of Louisville, Louisville
University of Illinois Hospital and Health Sciences System, Chicago
Willis-Knighton Physician Network, Shreveport
Road Runner Research, Ltd., San Antonio
Children's Blood and Cancer Center, Austin
Children's Hospital Colorado, Aurora
Children's Hospital of Los Angeles, Los Angeles
Long Beach Memorial Medical Center, Long Beach
Children's Health Center, Los Angeles
Connecticut Children's Medical Center, Hartford
Saint Peter's University Hospital, New Brunswick
Rhode Island Hospital, Department of Pediatrics, Providence
Purdue Pharma LP
INDUSTRY